Axel Wester

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Biträdande lektor i epidemiologi med fokus på kronisk leversjukdom samt ST-läkare i klinisk farmakologi på Karolinska universitetssjukhuset Huddinge.
Medlem i Hannes Hagströms forskargrupp vid institutionen för medicin,
Huddinge: https://ki.se/en/medh/hagstrom-group

Artiklar

Article: LIVER INTERNATIONAL. 2024;44(11):3050-3059
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
Nasr P; Shang Y; Wester A; Strandberg R; Widman L; Lazarus JV; Hagstrom H
Article: LIVER INTERNATIONAL. 2024;44(10):2551-2563
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
Astrom H; Shang Y; Hagstrom H; Wester A
Journal article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2024
Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients
Schechter MS; Widman L; Wester A; Shang Y; Stal P; Fortune B; Hagstroem H
Article: LIVER INTERNATIONAL. 2024;44(8):2002-2010
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study
Wester A; Jepsen P; Hagstrom H
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024;13(13):e034709
Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
Hakansson A; Koul S; Omerovic E; Andersson J; James S; Agewall S; Mokhtari A; van der Pals J; Wester A; Szummer K; Jernberg T; Erlinge D; Mohammad MA
Article: LIVER INTERNATIONAL. 2024;44(7):1689-1699
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(5):1048-1057.e2
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagstrom H
Article: GUT. 2024;73(5):835-843
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
Wester A; Shang Y; Grip ET; Matthews AA; Hagstrom H
Journal article: GASTRO HEP ADVANCES. 2024;3(6):783-792
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver Disease.
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3346-3355.e19
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study
Ebrahimi F; Simon TG; Hagstrom H; Soderling J; Wester A; Roelstraete B; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3336-3345.e2
Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients
Hagstroem H; Shang Y; Tapper EB; Wester A; Widman L
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.1371
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
Haakansson A; Koul S; Omerovic E; Andersson J; Agewall S; James S; Mokhtari A; Van der Pals J; Wester A; Szummer K; Jernberg T; Erlinge D; Mohammad MA
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(11):e0238
Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2023;46(6):1186-1194
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients
Lissing M; Wester A; Vassiliou D; Floderus Y; Harper P; Sardh E; Wahlin S
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):852-860
Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients
Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Article: LIVER INTERNATIONAL. 2023;43(10):2142-2152
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagstrom H; Wester A
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(10):e0279
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
Wester A; Shang Y; Stal P; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023;58(8):931-936
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients
Astrom H; Wester A; Hagstrom H
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(2):164-177
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study
Schoenau J; Wester A; Schattenberg JM; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s959-s960
Four-fold increased mortality rate in patients with Wilson's disease: a population-based cohort study of 151 patients
Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s302-s303
Secondary prevention of variceal bleeding is often imperfect: a national, population-based cohort study of 5,018 patients
Hagstrom H; Shang Y; Tapper E; Wester A; Widman L
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s276
Six-fold increased rate of chronic kidney disease after acute kidney injury: a population-based cohort study of 46,946 patients with cirrhosis
Cederborg A; Widman L; Haraldsson B; Lindkvist B; Shang Y; Wester A; Hagstrom H; Marschall H-U
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s960
Risk of cirrhosis and hepatocellular carcinoma in hemochromatosis: a Swedish nationwide cohort study
Astrom H; Wester A; Widman L; Stal P; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s600
Risk of bacterial infections in non-alcoholic fatty liver disease: a nationwide population-based cohort study
Wester A; Shang Y; Widman L; Ebrahimi F
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s46
Risk of cancer and subsequent mortality in primary biliary cholangitis: a population-based cohort study of 3,052 patients
Wester A; Schoenau J; Schattenberg J; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1271-1280.e7
Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study
Wester A; Ndegwa N; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(4):995-1004.e9
Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study
aberg F; Rajani R; Wester A; Widman L; Hagstrom H
Article: NATURE. 2023;615(7950):134-142
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Brevini T; Maes M; Webb GJ; John BV; Fuchs CD; Buescher G; Wang L; Griffiths C; Brown ML; Scott WEIII; Pereyra-Gerber P; Gelson WTH; Brown S; Dillon S; Muraro D; Sharp J; Neary M; Box H; Tatham L; Stewart J; Curley P; Pertinez H; Forrest S; Mlcochova P; Varankar SS; Darvish-Damavandi M; Mulcahy VL; Kuc RE; Williams TL; Heslop JA; Rossetti D; Tysoe OC; Galanakis V; Vila-Gonzalez M; Crozier TWM; Bargehr J; Sinha S; Upponi SS; Fear C; Swift L; Saeb-Parsy K; Davies SE; Wester A; Hagstrom H; Melum E; Clements D; Humphreys P; Herriott J; Kijak E; Cox H; Bramwell C; Valentijn A; Illingworth CJR; Dahman B; Bastaich DR; Ferreira RD; Marjot T; Barnes E; Moon AM; Barritt AS; Gupta RK; Baker S; Davenport AP; Corbett G; Gorgoulis VG; Buczacki SJA; Lee J-H; Matheson NJ; Trauner M; Fisher AJ; Gibbs P; Butler AJ; Watson CJE; Mells GF; Dougan G; Owen A; Lohse AW; Vallier L; Sampaziotis F
Article: GASTRO HEP ADVANCES. 2023;2(7):879-888
Risk of Cancer and Subsequent Mortality in Primary Biliary Cholangitis: A Population-based Cohort Study of 3052 Patients.
Schönau J; Wester A; Schattenberg JM; Hagström H
Article: LIVER INTERNATIONAL. 2022;42(12):2769-2780
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up
Holmer M; Ekstedt M; Nasr P; Zenlander R; Wester A; Tavaglione F; Romeo S; Kechagias S; Stal P; Hagstrom H
Article: JOURNAL OF INTERNAL MEDICINE. 2022;292(3):492-500
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Wester A; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(8):978-983
Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)
Hagstrom H; Shang Y; Wester A; Widman L
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s30
OS026 Liver stiffness predicts incident severe liver disease in patients with chronic liver disease
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren Å; Nasr P; Shahnavaz A; Vessby J; Westin J; Önnerhag K; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s123
THU010 Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study
Wester A; Ndegwa N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s423
FRI053 The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD
Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagström H
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2021;10(20):e020974
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study
Wester A; Mohammad MA; Olivecrona G; Holmqvist J; Yndigegn T; Koul S
Article: OPEN HEART. 2020;7(2):e001286
Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
Attar R; Wester A; Koul S; Eggert S; Polcwiartek C; Jernberg T; Erlinge D; Andell P
Article: CIRCULATION: CARDIOVASCULAR INTERVENTIONS. 2020;13(4):e008671
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
Wester A; Attar R; Mohammad MA; Isma N; James S; Omerovic E; Erlinge D; Koul S
Article: DIABETIC MEDICINE. 2019;36(11):1375-1383
Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus
Hampe CS; Radtke JR; Wester A; Carlsson A; Cedervall E; Jonsson B; Ivarsson SA; Elding Larsson H; Larsson K; Lindberg B; Neiderud J; Rolandsson O; Lernmark A
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(16):e012741
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial
Wester A; Attar R; Mohammad MA; Andell P; Hofmann R; Jensen J; Szummer K; Erlinge D; Koul S
Article: OPEN HEART. 2019;6(1):e001004
Peripheral artery disease and outcomes in patients with acute myocardial infarction
Attar R; Wester A; Koul S; Eggert S; Andell P
Article: RESUSCITATION. 2018;126:172-178
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: A SWEDEHEART study
Wester A; Mohammad MA; Andell P; Rylance R; Dankiewicz J; Friberg H; James S; Omerovic E; Erlinge D; Koul S
Article: DIABETES. 2017;66(3):735-740
An Increased Diagnostic Sensitivity of Truncated GAD65 Autoantibodies in Type I Diabetes May Be Related to I-ILA-DQ8
Wester A; Skarstrand H; Lind A; Ramelius A; Carlsson A; Cedervall E; Jonsson B; Ivarsson SA; Larsson HE; Larsson K; Lindberg B; Neiderud J; Fex M; Torn C; Lernmark A
Visa fler

Alla övriga publikationer

Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(3):670
Secondary Prevention of Esophageal Variceal Bleeding: Still a Long Way to Go Reply
Hagstrom H; Shang Y; Tapper EB; Wester A; Widman L
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2024;62(01):e15
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):537-538
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis
Schoenau J; Wester A; Hagstrom H; Schattenberg JM
Editorial comment: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(10):2689-2691.e1
Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study
Wester A; Aberg F; Rajani R; Hagstrom H
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2023;61(08):e472-e473
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(6):1678
Letter on "Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study" Reply
Wester A; Hagstrom H
Conference publication: HEPATOLOGY. 2023;78:S395-S396
LOWER INCIDENCE OF HCC AND OTHER MAJOR ADVERSE LIVER OUTCOMES IN PEOPLE LIVING WITH HIV AND CHRONIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY
Michel M; Hagstrom H; Widman L; Nowak P; Shang Y; Schattenberg J; Wester A
Conference publication: HEPATOLOGY. 2023;78:S1668-S1669
UPTAKE OF SECONDARY PREVENTIVE DRUGS AFTER MYOCARDIAL INFARCTION IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE IS LOW: A NATIONWIDE POPULATION-BASED STUDY
Wester A; Hagstrom H; Jepsen P
Conference publication: HEPATOLOGY. 2022;76:S1133-S1134
RISK OF INJURY BEFORE AND AFTER DIAGNOSIS OF CIRRHOSIS: A SELF-CONTROLLED CASE SERIES STUDY
Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S423
The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD
Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S30
Liver stiffness predicts incident severe liver disease in patients with chronic liver disease
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S1491
RISK OF FRACTURES AND POST-FRACTURE MORTALITY IN PRIMARY BILIARY CHOLANGITIS: A POPULATION-BASED COHORT STUDY OF 3,980 PATIENTS
Wester A; Schoenau J; Schattenberg JM; Hagstroem H
Conference publication: HEPATOLOGY. 2022;76:S949
TIME TRENDS FOR MORTALITY AND LIFE EXPECTANCY IN 22,658 PATIENTS HOSPITALIZED WITH ALCOHOL-RELATED CIRRHOSIS IN SWEDEN: A NATIONWIDE COHORT STUDY
Wester A; Shang Y; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S123
Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study
Wester A; Ndegwa N; Hagstrom H
Conference publication: EUROPEAN HEART JOURNAL. 2020;41:1435
External validation of the PRECISE-DAPT score in a large nationwide population of myocardial infarction patients: a SWEDEHEART study
Wester A; Mohammad MA; Erlinge D; Koul S
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2017;70(18):B1
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction: a SWEDEHEART study
Wester A; Mohammad M; Koul S; Andell P; Rylance R; Dankiewicz J; Friberg H; James S; Omerovic E; Erlinge D

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Handledare

Nyheter från KI

Kalenderhändelser från KI